Report Categories
View AllRecent Articles
View All
TC Energy TRP Stock Throwback Trade 102 20260415
How Archrock AROC talent strategy drives results Q1 2026 Earnings Underperform
INNV InnovAge Holding shares plunge 631 as Q1 earnings miss by 4595 shocks investors
Should I buy or sell Cingulate CING stock today Q4 2025 Earnings Fall Short
AFL AFLAC shares climb 1 despite Q1 earnings miss defying low analyst expectations
Is Braze BRZE stock attractive today Q1 2026 Earnings Fall Short
What makes PayPay PAYP a safer bet than newer entrants Selling Pressure 20260511
Telomir Pharmaceuticals TELO Q4 2025 Disappoints EPS 028 Below 007 Views
Retirement at 60 With 2700 Monthly Expenses Are Dan and Carol Still Falling Short
AI Could Deter People from Tech Careers Potentially Harming Economy Warns Raspberry Pi CEO
Senti Biosciences SNTI Q1 2026 Earnings Surprise EPS 036 Up Significant
Global Bond Yields Surge 10Year Treasury Hits OneYear High Japans 30Year Yield Reaches Record
Republic Services RSG Q1 2026 Earnings Why the Beat Matters
Hajj 2026 Over 15 Million Foreign Pilgrims Arrive in Saudi Arabia Amid Regional Tensions
Walmart Price Target Lowered by UBS to 141 After Q1 Results
SpaceX IPO Buzz Nvidia Earnings and Bezos on AI Key Market Themes
RubioModi Talks Focus on US Energy Sales Amid IranLed Supply Disruptions
CrowdStrike Launches New Integration with Claude Compliance API Expanding AIPowered Security Offerings
Bill Gates Discusses Trump Meeting Musks DOGE and Childhood in WSJ Interview
Scinai Immunotherapeutics SCNI Q4 2023 Earnings NarrowerThanExpected Loss Amid Operational Adjustments
ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Consumer Demand
PROK Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Development Continues
Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline
C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution
NBN Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline
Revvity Inc RVTY Gains 165 as Price Approaches Key Resistance
LivePerson LPSN Gains 45 as Stock Tests Key Resistance Level
Sterling Infrastructure STRL Holds Steady as Key Technical Levels Come into Focus
DigitalBridge Group DBRG Holds Near Support After Minimal Gains
Kura Oncology KURA Stages a Rally Testing Key Resistance at 12